Artikel ; Online: CD80 expression is upregulated by TP53 activation in human cancer epithelial cells.
2021 Band 10, Heft 1, Seite(n) 1907912
Abstract: CD80 is recognized as one of the most potent costimulatory molecules by which immune cells limit cancer progression; however, the current understanding of the regulation of its expression on human tumor cells is limited. The TP53 tumor suppressor plays a ...
Abstract | CD80 is recognized as one of the most potent costimulatory molecules by which immune cells limit cancer progression; however, the current understanding of the regulation of its expression on human tumor cells is limited. The TP53 tumor suppressor plays a critical role in cancer and its significant role in the control of immune responses is emerging. Here, we evaluated the role of TP53 as a regulator of CD80 expression in human cancer cells. A set of well-known TP53-reactivating compounds were used on TP53-wild-type, TP53-deficient, TP53-mutated and TP53-knockdown cancer cell lines to determine if TP53 can regulate CD80. CD80 expression was analyzed in samples from patients with TP53-active vs TP53-inactive Colon Adenocarcinomas (COAD) from TCGA panCancer Atlas. We report that the pharmacological activation of TP53 can stimulate the expression of CD80 in human tumor cells of epithelial origin. We also provide evidence that CD80 expression exhibits a strong correlation with TP53 activation in a subgroup of colon tumors with better overall survival. These results confirm the link between TP53 and immune surveillance in human cancer and provide the possibility that conventional TP53-activation approaches for tumoricidal effects may be repurposed for immunotherapy strategies. |
---|---|
Mesh-Begriff(e) | B7-1 Antigen/genetics ; Cell Adhesion Molecules ; Colonic Neoplasms/genetics ; Epithelial Cells ; Humans ; Immunotherapy ; Tumor Suppressor Protein p53/genetics |
Chemische Substanzen | B7-1 Antigen ; Cell Adhesion Molecules ; TP53 protein, human ; Tumor Suppressor Protein p53 |
Sprache | Englisch |
Erscheinungsdatum | 2021-04-05 |
Erscheinungsland | United States |
Dokumenttyp | Journal Article ; Research Support, Non-U.S. Gov't |
ZDB-ID | 2645309-5 |
ISSN | 2162-402X ; 2162-4011 |
ISSN (online) | 2162-402X |
ISSN | 2162-4011 |
DOI | 10.1080/2162402X.2021.1907912 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.